Home » Headlines » Currently Reading:

Morning Headlines 11/30/17

November 30, 2017 Headlines No Comments

Nuance Fourth Quarter and Fiscal 2017

Nuance releases Q4 results: adjusted revenue fell to $466 million, compared to $506.2 during the same quarter last year, adjusted EPS -$0.23 vs. $0.06, beating estimates on both and driving share prices up 3.2 percent in after hours trading. In its financial statements, the company noted that costs associated with its NotPetya cyberattack totaled $53 million in Q4, less than the $65 – $75 million range it initially estimated.

Is It Time for a New Medical Specialty? The Medical Virtualist

An article in JAMA proposes creating a medical virtualist specialty that would focus primarily on providing telehealth-based services.

Medicare Part D Opioid Prescribing Mapping Tool

CMS releases new data visualizations showing geo-located Medicare Part D opioid prescribing rates from 2013 to 2015 with additional information on extended-release opioid prescribing rates and spatial analyses to identify “hot spots.”

Remarks by Dr. Gottlieb at FDA’s Generic Drug Science Day

FDA Commissioner Scott Gottlieb, MD says the agency is approving record numbers of generic drugs in its push to speed up the “approval of safe, high-quality, and more affordable generic drugs.”

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links